Results 101 to 110 of about 1,190,674 (269)

Examining the Relationship Between the Therapeutic Bond and the Phases of Treatment Outcome [PDF]

, 2000
Examined the association between the therapeutic bond—an element of the therapeutic alliance—and treatment effectiveness. 114 psychotherapy clients completed self-report questionnaires at intake and throughout open-ended, psychodynamically oriented ...
Saunders, Stephen M.
core   +1 more source

Peripheral blood biomarkers in multiple sclerosis. [PDF]

, 2015
Multiple sclerosis is the most common autoimmune disorder affecting the central nervous system. The heteroge-neity of pathophysiological processes in MS contributes to the highly variable course of the disease and unpre-dictable response to therapies ...
Acheson, Achiron, Ada Francia, Agmon-Levin, Aktas, Alatab, Alexander, Amorini, Anderson, Antonella D'Ambrosio, Arbour, Arnson, Arrambide, Ascherio, Ascherio, Ascherio, Axtell, Bar-Or, Barkhof, Barkhof, Barteneva, Bartosik-Psujek, Berger, Bertolotto, Bertolotto, Bertolotto, Bianco, Bielekova, Biomarkers Definitions Working Group, Bittner, Bloomgren, Braun, Brettschneider, Brex, Browne, Burger, Bustamante, Bustamante, Buttmann, Buzas, Bălaşa, Cantorna, Carotenuto, Carson, Cermelli, Chabas, Chen, Ciusani, Clifford, Cocucci, Colombo, Comabella, Comabella, Comabella, Comabella, Comi, Confavreux, Correale, Corvol, Cox, Creeke, D'Aurizio, D'Souza, Dalmau, De Jager, De Jager, De Santis, Deisenhammer, Derfuss, Dhib-Jalbut, Distler, Doyle, Du, Egg, Ehling, Eikelenboom, Engelhardt, Esteller, Eulalio, Fabriek, Farrell, Fenoglio, Fialová, Fissolo, Fonalledas Perelló, Fox, Freedman, Friedman, Galboiz, Gandhi, Gao, Ge, Gianchecchi, Gilli, Gilli, Giovannoni, Goldberg, Goodin, Graber, Graber, Gresle, Gresle, Guo, Haak, Haller, Hanke, Harris, Hartung, Hayes, Hecker, Hecker, Hellerqvist, Hinson, Horstman, Huang, Huang, Hur, Inoue, Ioannidis, Jimenez, Johnson, Julien, Junker, Kacperska, Kallaur, Kamath, Kasper, Kayagaki, Keller, Kemppinen, Knox, Korn, Korteweg, Kuenz, Kuhle, Kurtzke, Kvistad, Kwon, Lai, Lalive, Laroni, Lassmann, Lassmann, Lau, Lemire, Leppert, Leray, Lewis, Liang, Lily, Lin, Lindberg, Linington, Liotta, Littman, Liu, Lolli, Lopatinskaya, Lopatinskaya, Losseff, Losseff, Losy, Lovett-Racke, Lowery-Nordberg, Lublin, Lublin, Lucchinetti, Lycke, Lünemann, Lünemann, Major, Malucchi, Marchi, Markiewicz, Markovic-Plese, Martinelli-Boneschi, Marzesco, Masuoka, Mayer, Mazzali, McDonald, Miller, Minagar, Minagar, Minagar, Minagar, Missler, Mitchell, Momen-Heravi, Morel, Moreno, Mowry, Munger, Muralidharan-Chari, Murugaiyan, Myers, Nelissen, Nelissen, Norling, O'Connell, O'Connell, Oliveira, Oliver, Opdenakker, Opsahl, Otaegui, Pachner, Pachner, Pachner, Paola Margutti, Papini, Park, Pawate, Pelajo, Pender, Petereit, Peterson, Petrocca, Poloni, Probstel, Qin, Qu, Quintana, Redell, Reder, Reindl, Reindl, Rieckmann, Rieder, Riverol, Romo-Tena, Rovaris, Rudick, Rudick, Rudick, Sadiq, Salama, Sato, Schwarz, Schwarz, Selmi, Semra, Sendid, Sharief, Sharief, Sharief, Sharief, Shaw, Sheremata, Sievers, Silber, Silvia Zamboni, Siman, Simona Pontecorvo, Simpson, Soldan, Soldan, Sospedra, Srivastava, Stewart, Stüve, Sundström, Sáenz-Cuesta, Sáenz-Cuesta, Tania Colasanti, Tao, Teunissen, Tintoré, Trabattoni, Trampe, Turiák, van Horssen, Varga, Vartanian, Verderio, Villoslada, Virtanen, Vogt, Vogt, Wandinger, Wang, Waschbisch, Waubant, Waubant, Waubant, Waubant, Weinstock-Guttman, Wekerle, Xiao, Yong, Yong, Yousry, Zahednasab, Zang, Zhang, Zhu, Zipp, Zisimopoulou, Zula   +298 more
core   +1 more source

Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development

Clinical and Translational Medicine, 2014
Biomarker research is continuously expanding in the field of clinical proteomics. A combination of different proteomic–based methodologies can be applied depending on the specific clinical context of use.
Maria Frantzi, Akshay Bhat, Agnieszka Latosinska   +2 more
doaj   +1 more source

International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials

Annals of the Rheumatic Diseases, 2016
Objective To identify a core set of domains (outcomes) to be measured in psoriatic arthritis (PsA) clinical trials that represent both patients' and physicians' priorities. Methods We conducted (1) a systematic literature review (SLR) of domains assessed
A. Orbai, M. D. de Wit, P. Mease, J. Shea, L. Gossec, Ying-Ying Leung, W. Tillett, M. Elmamoun, K. Callis Duffin, Willemina Campbell, R. Christensen, L. Coates, E. Dures, L. Eder, O. FitzGerald, D. Gladman, N. Goel, S. Grieb, S. Hewlett, P. Hoejgaard, U. Kalyoncu, C. Lindsay, N. McHugh, B. Shea, I. Steinkoenig, V. Strand, A. Ogdie   +26 more
semanticscholar   +1 more source

Dissemination and implementation science training needs: Insights from practitioners and researchers [PDF]

, 2017
INTRODUCTION: Dissemination and implementation research training has great potential to improve the impact and reach of health-related research; however, research training needs from the end user perspective are unknown.
Brownson, Ross C, Chambers, David A, Colditz, Graham A, Dobbins, Maureen J, Kerner, Jon F, Padek, Margaret M, Proctor, Enola K, Strange, Kurt C, Tabak, Rachel G   +8 more
core   +2 more sources

Challenges and burden of the Coronavirus 2019 (COVID-19) pandemic for child and adolescent mental health: a narrative review to highlight clinical and research needs in the acute phase and the long return to normality [PDF]

, 2020
Jörg M. Fegert, Benedetto Vitiello, Paul L. Plener, Vera Clemens   +3 more
openalex   +1 more source

BATRACIO: BAsic, TRAnslational, Clinical, Research Phase Identification in BiOmedical Publications

IEEE Access
The increasing interest from research agencies, governments, and universities in understanding research funding and prioritising research efforts has highlighted the need for reliable and efficient methods for exploring research portfolios. In biomedical research, this involves exploring research across what is normally considered fundamental and ...
Nicolau Durán-Silva, Jorge Carrillo-de-Albornoz, Laura Plaza, Sara Ricardo, Francesco A. Massucci, Sonia Veiga, Arnau Ramos-Prats   +6 more
openaire   +2 more sources

Preliminary Results of the Louisiana Sex Offender Treatment Program [PDF]

, 2015
The purpose of this study was to offer preliminary support for the Louisiana Sex Offender Treatment Program (LSOTP) in addressing the needs of juvenile sex offenders.
Crump, Yolanda, Dailey, Frances L.L., Merino, Carrie, Underwood, Lee A.   +3 more
core   +3 more sources

Improving Participant Recruitment in Clinical Trials: Comparative Analysis of Innovative Digital Platforms

Journal of Medical Internet Research
BackgroundPharmaceutical product development relies on thorough and costly clinical trials. Participant recruitment and monitoring can be challenging.
Alexia Georgia Bikou, Elena Deligianni, Foteini Dermiki-Gkana, Nikolaos Liappas, José Gabriel Teriús-Padrón, Maria Eugenia Beltrán Jaunsarás, Maria Fernanda Cabrera-Umpiérrez, Christos Kontogiorgis   +7 more
doaj   +1 more source

Gender differences in clinical registration trials: is there a real problem?

British Journal of Clinical Pharmacology, 2018
Aims Several studies have reported the under‐representation of women in clinical trials, thereby challenging the external validity of the benefit/risk assessments of launched drugs. Our aim was to determine the extent to which women have been included in
Geert Labots, Aubrey Jones, Saco J de Visser, R. Rissmann, J. Burggraaf   +4 more
semanticscholar   +1 more source